@misc{indiciaec871ed7104e3,
  title = {A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination},
  author = {Ranzani, M. and Kemper, K. and Michaut, M. and Krijgsman, O. and Aben, N. and Iyer, V. and Wong, K. and Roumeliotis, T. I. and Del Castillo Velasco-Herrera, M. and Nsengimana, J. and Turner, G. and Thompson, N. and Shahrabi, A. and Sjoberg, M. and Rashid, M. and Speak, A. O. and Grinkevich, V. and Behan, F. and Tamborero, D. and Iorio, F. and van Dongen, S. and Bignell, G. R. and Alsinet, C. and Chen, S. and Supper, E. and Dutton-Regester, K. and Pritchard, A. and Wong, C. and Enright, A. and Newton-Bishop, J. and McDermott, U. and Hayward, N. K. and Choudhary, J. S. and Yusa, K. and Wessels, L. and Garnett, M. J. and Peeper, D. and Adams, D. J.},
  year = {2017},
  doi = {10.1101/195354},
  url = {https://www.biorxiv.org/content/10.1101/195354v1},
  note = {Source identifier: 10.1101/195354}
}